| Summary: | Atopic eczema affects many adults and up to 20% of children,1 with health costs comparable to diabetes2 and asthma.3 One community survey of 1760 young children in the United Kingdom found that 84% had mild eczema, 14% moderate, and 2% severe eczema.4 Topical corticosteroids are a mainstay of treatment for inflammatory episodes.5 Most long established topical corticosteroids such as betamethasone valerate
or hydrocortisone are applied at least twice daily, but three newer preparations (mometasone, fluticasone,
and methylprednisolone) have been developed
for once daily application. Here, I propose that established preparations need be applied only once daily.
|
|---|